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Patient report
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Triple A syndrome with a novel indel mutation  
in the AAAS gene and delayed puberty
Abstract: Triple A syndrome, formerly known as Allgrove 
syndrome, is an autosomal recessive disorder charac-
terized clinically by adrenal insufficiency, alacrima, 
achalasia, and neurological abnormalities. We report a 
17-year-old boy presented to the endocrine clinic with 
delayed puberty and a 4-year’s history of fatigue and 
muscle weakness. He had achalasia, alacrima, and skin 
and mucosal hyperpigmentation. Hormonal assessment 
revealed isolated glucocorticoid deficiency. Clinical diag-
nosis of triple A syndrome was confirmed by sequencing 
the entire coding region including exon-intron boundaries 
of the AAAS gene. Analysis revealed a homozygous novel 
indel mutation encompassing intron 7 to intron 10 of the 
gene (g.16166_17813delinsTGAGGCCTGCTG; NG_016775). 
This is the first report of triple A syndrome in Jordan 
with a novel indel mutation and presenting with delayed 
puberty.
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Introduction
Triple A syndrome or Allgrove syndrome (MIM231550) 
is a rare disease of autosomal recessive inheritance first 
described in 1978 with the typical triad of adrenocortico-
tropic hormone (ACTH)-resistant adrenal insufficiency, 
reduced or absent tearing (alacrima), and achalasia 
(1). Clinically, the syndrome is highly variable and may 
include symptoms and signs such as neurological and 
dermatological abnormalities (2), although there are also 
patients without further symptoms as the typical nasal 
speech or frequently occurring palmoplantar hyperkera-
tosis and hyperreflexia (3). Correct diagnosis of this rare 
genetic disease is therefore of paramount importance to 
ensure optimal treatment and follow-up of patients and 
their families. Mutations in the achalasia-addisonianism-
alacrima syndrome (AAAS) gene on chromosome 12q13 
have been described in several pedigrees with triple A 
syndrome (4, 5). Usually, patients with this syndrome 
enter puberty at an appropriate age. Here we report a 
17-year-old boy with triple A syndrome presenting with 
delayed puberty and a confirmed homozygous novel indel 
mutation in the AAAS gene.
Case presentation
Clinical studies
A 17-year-old male presented to our endocrine clinic with 
delayed puberty and a 4-year’s duration of fatigue and 
muscle weakness. The patient was born at term after an 
uneventful pregnancy to double first-cousin parents 
(Figure 1A). Developmental milestones were normal. The 
parents noticed that since birth he had always cried without 
tears. He also complained of dry mouth and photophobia. 
At the age of 14 years, the patient did not show any second-
ary sexual characteristics and had poor weight gain, but 
the family was reassured by a local practitioner. At 16 years 
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Figure 1: (A) Pedigree of the index patient (arrow) with triple A syndrome; (B–E) characterization of the novel AAAS indel mutation on 
genomic and mRNA level: (B) RT-PCR analysis on RNA from patient (Pat.) and control (Contr.) cells. Using primers from the coding region of 
the AAAS gene (exon 7 and exon 12), we obtained a 169-bp and a 364-bp fragment from patient’s cDNA instead of the 567-bp fragment from 
control cDNA. Neg. = PCR negative control with water instead of cDNA. (C) Fragment analysis of PCR amplification of patient (Pat.), parents 
(Fath.+Moth.) and wildtype (Contr.) genomic DNA. (D) DNA sequence chromatogram representing the breakpoint of deletion in intron 7 and 
the insertion of a 12-bp nucleotide sequence ahead of exon 11. (E) Schematic illustration of the AAAS gene structure and the deletion from 
intron 7 to exon 11 in the DNA of the patient.
he still showed no secondary sexual characteristics, low 
luteinizing hormone (LH) levels, only minimal change in 
scrotal texture with slightly pigmented hair, straight at the 
base of the penis (G1, P2), and testes  < 3 mL bilaterally. For 
the induction of puberty he received 100 mg testosterone 
injections monthly for 6  months without improvement, 
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and when he presented to our endocrine clinic he was off 
treatment for more than 2 months. At presentation, exami-
nation revealed pigmented mucous membranes, a fis-
sured and dry tongue, palmar and plantar keratosis, distal 
muscle atrophy, marked hyperreflexia on upper and lower 
extremities, absent secondary sexual characteristics, and 
no gynecomastia. Laboratory tests including complete 
blood count, analysis of blood and urine electrolytes, 
and assessment of renal and hepatic functions revealed 
no abnormalities. Hormonal profile revealed an isolated 
glucocorticoid deficiency with diminished cortisol level 
of 4.8 mg/dL (normal value 7–25) and an elevated ACTH 
level of 948 pg/mL (normal value 7–63). Follicle-stimulat-
ing hormone and LH levels were prepubertal. Mineralo-
corticoid level as well as thyroid and insulin-like growth 
factor I levels were within normal ranges. Chest radio-
graphy, abdominal ultrasound, and electrocardiography 
were unremarkable. Ophthalmologic assessment revealed 
alacrima and bilateral partial optic atrophy. Achalasia was 
confirmed by esophageal manometry.
Glucocorticoid deficiency was treated with oral sup-
plementation of hydrocortisone (20 mg/day) in three 
daily divided doses (10, 5, and 5 mg), which resulted in an 
improvement of the fatigue and weakness and a normali-
zation of the hyperpigmentation of skin and mucosa. Once 
we had given hydrocortisone replacement, he improved 
gradually.
The one affected cousin had no delayed puberty; there 
was one infant who died and another 10-year-old affected 
male cousin (Figure 1A).
To confirm the clinical diagnosis of triple A syndrome, 
molecular analysis of the AAAS gene was done. Written 
informed parental consent was obtained for all clini-
cal and molecular studies. The study was performed in 
accordance with the Declaration of Helsinki.
Molecular genetics and functional analysis
Blood samples from the patient and his parents were 
collected, and deoxyribonucleic acid (DNA) prepara-
tion was performed according to standard protocols 
using the QIAamp DNA Mini Kit (Qiagen GmbH, Hilden, 
Germany). Coding sequences of the 16 exons of AAAS, 
including exon-intron boundaries, were amplified from 
genomic DNA. Primer sequences and polymerase chain 
reaction (PCR) conditions used for amplification are 
available upon request. Total RNA from patient’s blood 
collected into a PAXgene Blood RNA Tube (BD, Heidel-
berg, Germany) was prepared using PAXgene Blood 
RNA Kit (Qiagen GmbH, Hilden, Germany). After reverse 
transcription of messenger ribonucleic acid (mRNA) 
with Go Script™ Reverse Transcription System (Promega 
GmbH, Mannheim, Germany), the sequences of exons 7–12 
were amplified using the forward primer (exon  7) CCAT-
AGTCCCCTCCCTGAAG and the reverse primer (exon 12) 
CACCTCCAACGCACCCCT. To identify the breakpoints and 
the rearrangement of the DNA, we amplified the genomic 
DNA using an intron 7 forward primer (ACTGGAGCTGAA-
GGTGGTTA) and the reverse primer from exon 12. PCR 
products were purified using QIAquick columns (Qiagen 
GmbH, Hilden, Germany) and sequenced on an ABI 
3130XL genetic analyzer using BigDye Terminator Cycle 
Sequencing Kit 1.1 (Applied Biosystems, Forster City, USA).
Results
Sequencing of the genomic DNA of the patient using 
the specific AAAS gene sequencing primers revealed a 
homozygous deletion of exons 8, 9, and 10. Analysis of 
parental DNA after amplification of exons 8, 9, and 10 
showed the wildtype sequence. These results suggested 
that a large deletion involving exons 8–10 had occurred in 
the patient’s AAAS gene. Both parents should be heterozy-
gous for this mutation, and only the wild-type allele of the 
parent’s DNA was amplified.
Reverse transcription-PCR (RT-PCR) analysis on RNA 
from patient and control cells showed that the deletion 
leads to a splicing defect (Figure 1B). To amplify the com-
plementary DNA (cDNA) of the patient, a primer pair from 
exon 7 and exon 12 was used. In the patient, a 169-bp and 
a 364-bp fragment instead of the expected 567-bp frag-
ment were obtained.
As the splice acceptor site of intron 10 was deleted, 
one product was without exon 8–11 (169 bp), and in the 
other product (364 bp) a cryptical acceptor splice site in 
intron 7 was used. This results in a cryptic exon consisting 
of a part of intron 7 followed by a 12-bp insert of unknown 
sequence and the sequence of exon 11.
After sequencing of genomic and RT-PCR-fragments 
we were able to reconstruct the rearrangement in the 
patient’s DNA (Figure 1C–E). There was a 1648-bp dele-
tion including a part of intron 7, exons 8–10, and intron 
10. Instead of this sequence, an insertion of an unknown 
12-bp nucleotide sequence is located ahead of exon 11 
(Figure 1D). The splice acceptor site of intron 10 was also 
deleted (Figure 1E). According to the nomenclature of the 
Human Genome Variation Society (HGVS; http://www.
hgvs.org/mutnomen), this mutation is referred to as 
g.16166_17813delinsTGAGGCCTGCTG (GenBank accession 
no. NG_016775).
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Discussion
This is the first report of triple A syndrome from Jordan 
describing the clinical and molecular finding in a 17-year-
old male presenting with delayed puberty. In addition to 
the typical triad of adrenal insufficiency, achalasia, and 
alacrima, neurological features are frequently associated 
with triple A syndrome and may result in a severe disa-
bling disease. Our patient, in addition to the classical triad 
of triple A syndrome, had other manifestations including 
muscle weakness, optic atrophy, and palmoplantar kera-
tosis. He also presented with delayed puberty. There is 
only one male patient with triple A syndrome from Poland 
who was reported to show delayed puberty (6). This inde-
pendent case supports our hypothesis that a loss of func-
tion in the protein ALADIN (ALacrima Achalasia aDrenal 
Insufficiency Neurologic disorder) is the modifier for the 
pubertal delay.
Triple A syndrome has been reported in the popula-
tions of the Middle East and North Africa including Alge-
rian, Tunisian (5), Moroccan, and Turkish (4) populations. 
These populations show consanguinity rates that reach up 
to 20%–50%, with about 20% of all marriages contracted 
between first cousins (7). Such high consanguinity rates 
are expected to increase the expression of rare autosomal 
recessive conditions such as the triple A syndrome. Health 
care providers in different specialities could be alerted 
to the possibility of encountering patients with this syn-
drome showing variable presentations and a highly vari-
able expression of the different symptoms of the disease. 
The most severe presentation could be adrenal insuffi-
ciency necessitating urgent supplementation of hydrocor-
tisone in the newborn and infancy periods.
AAAS is highly expressed in the pituitary gland (4) 
which may serve as a possible explanation for the impair-
ment of pituitary function. However, this is apparently a 
rare feature of triple A syndrome as most patients enter 
puberty at normal time.
Sequencing of genomic DNA and cDNA of the AAAS 
gene revealed a novel homozygous indel mutation 
g.16166_17813delinsTGAGGCCTGCTG (GenBank accession 
no. NG_016775). This mutation leads to an aberrant splic-
ing with two splice products. In one product the exons 
8–11 are deleted in the transcript. This results in trans-
lation in a premature stop codon at amino acid position 
231. In the other product a cryptical exon is included. This 
results in a frame shift mutation at amino acid position 
231 with a premature stop codon at amino acid position 
296 (Pro231Argfs*66). Both ALADIN variants are truncated 
and probably not functional. Beside the first report of an 
Alu-mediated rearrangement of the AAAS gene in 2007 
(8), this novel indel mutation is the second mutation with 
a rearrangement in the AAAS gene.
In conclusion, in addition to the classical triad, triple 
A syndrome could present with delayed puberty.
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